Your browser doesn't support javascript.
loading
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
Maida, Elisabetta; Moccia, Marcello; Palladino, Raffaele; Borriello, Giovanna; Affinito, Giuseppina; Clerico, Marinella; Repice, Anna Maria; Di Sapio, Alessia; Iodice, Rosa; Spiezia, Antonio Luca; Sparaco, Maddalena; Miele, Giuseppina; Bile, Floriana; Scandurra, Cristiano; Ferraro, Diana; Stromillo, Maria Laura; Docimo, Renato; De Martino, Antonio; Mancinelli, Luca; Abbadessa, Gianmarco; Smolik, Krzysztof; Lorusso, Lorenzo; Leone, Maurizio; Leveraro, Elisa; Lauro, Francesca; Trojsi, Francesca; Streito, Lidia Mislin; Gabriele, Francesca; Marinelli, Fabiana; Ianniello, Antonio; De Santis, Federica; Foschi, Matteo; De Stefano, Nicola; Morra, Vincenzo Brescia; Bisecco, Alvino; Coghe, Giancarlo; Cocco, Eleonora; Romoli, Michele; Corea, Francesco; Leocani, Letizia; Frau, Jessica; Sacco, Simona; Inglese, Matilde; Carotenuto, Antonio; Lanzillo, Roberta; Padovani, Alessandro; Triassi, Maria; Bonavita, Simona; Lavorgna, Luigi.
Affiliation
  • Maida E; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Via Pansini 5, 80131, Naples, Italy.
  • Moccia M; Department of Molecular Medicine and Medical Biotechnology, Federico II University of Naples, Naples, Italy.
  • Palladino R; Multiple Sclerosis Unit, Policlinico Federico II University Hospital, Naples, Italy.
  • Borriello G; Department of Public Health, University "Federico II" of Naples, Naples, Italy.
  • Affinito G; Department of Primary Care and Public Health, Imperial College of London, London, UK.
  • Clerico M; Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
  • Repice AM; Department of Public Health, University "Federico II" of Naples, Naples, Italy.
  • Di Sapio A; Dipartimento di Scienze Cliniche e Biologiche, Università Di Torino, Turin, Italy.
  • Iodice R; Department of Neurology 2 and Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy.
  • Spiezia AL; Department of Neurology and Multiple Sclerosis Regional Referral Centre, AOU San Luigi Gonzaga, Orbassano, Turin, Italy.
  • Sparaco M; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Miele G; Multiple Sclerosis Unit, Policlinico Federico II University Hospital, Naples, Italy.
  • Bile F; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Via Pansini 5, 80131, Naples, Italy.
  • Scandurra C; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Via Pansini 5, 80131, Naples, Italy.
  • Ferraro D; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Via Pansini 5, 80131, Naples, Italy.
  • Stromillo ML; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Docimo R; Department of Neuroscience, Azienda Ospedaliero-Universitaria di Modena, Modena, Emilia-Romagna, Italy.
  • De Martino A; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Mancinelli L; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Abbadessa G; Multiple Sclerosis Center, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Smolik K; Institute of Neurology, University Magna Graecia of Catanzaro, Catanzaro, Italy.
  • Lorusso L; Neurology Unit, Bufalini Hospital, Local Health Agency of Romagna, Cesena, Italy.
  • Leone M; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Via Pansini 5, 80131, Naples, Italy.
  • Leveraro E; Department of Brain Sciences, Imperial College London, London, W120BZ, UK.
  • Lauro F; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Trojsi F; Neurology Unit-Neuroscience Department A.S.S.T.Lecco, Merate Hospital, 23807, Merate, Italy.
  • Streito LM; Neurology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013, San Giovanni Rotondo, Italy.
  • Gabriele F; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
  • Marinelli F; Department of Neurology, IRCSS Ospedale Policlinico San Martino, Genoa, Italy.
  • Ianniello A; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • De Santis F; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Via Pansini 5, 80131, Naples, Italy.
  • Foschi M; Dipartimento di Scienze Cliniche e Biologiche, Università Di Torino, Turin, Italy.
  • De Stefano N; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Morra VB; Neurology Unit, Multiple Sclerosis Center, Fabrizio Spaziani Hospital, Frosinone, Italy.
  • Bisecco A; Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
  • Coghe G; Department of Neurology and Stroke Unit of Avezzano-Sulmona, ASL 1 Avezzano-Sulmona-L'Aquila, L'Aquila, Italy.
  • Cocco E; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Romoli M; Department of Neuroscience, Multiple Sclerosis Center, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy.
  • Corea F; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Leocani L; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Frau J; Multiple Sclerosis Center, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Sacco S; Department of Medical Sciences and Public Health, Multiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, University of Cagliari, Cagliari, Italy.
  • Inglese M; Department of Medical Sciences and Public Health, Multiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, University of Cagliari, Cagliari, Italy.
  • Carotenuto A; Neurology Unit, Bufalini Hospital, Local Health Agency of Romagna, Cesena, Italy.
  • Lanzillo R; Dipartimento di Neurologia, Ospedale di Foligno, Azienda USL Umbria 2, Terni, Italy.
  • Padovani A; Vita-Salute San Raffaele University, Milan, Italy.
  • Triassi M; Experimental Neurophysiology Unit, Institute of Experimental Neurology-INSPE, IRCCS Scientific Institute San Raffaele, Milan, Italy.
  • Bonavita S; Department of Medical Sciences and Public Health, Multiple Sclerosis Center, Binaghi Hospital, ASL Cagliari, University of Cagliari, Cagliari, Italy.
  • Lavorgna L; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
J Neurol ; 271(7): 4057-4066, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38568227
ABSTRACT

BACKGROUND:

ChatGPT is an open-source natural language processing software that replies to users' queries. We conducted a cross-sectional study to assess people living with Multiple Sclerosis' (PwMS) preferences, satisfaction, and empathy toward two alternate responses to four frequently-asked questions, one authored by a group of neurologists, the other by ChatGPT.

METHODS:

An online form was sent through digital communication platforms. PwMS were blind to the author of each response and were asked to express their preference for each alternate response to the four questions. The overall satisfaction was assessed using a Likert scale (1-5); the Consultation and Relational Empathy scale was employed to assess perceived empathy.

RESULTS:

We included 1133 PwMS (age, 45.26 ± 11.50 years; females, 68.49%). ChatGPT's responses showed significantly higher empathy scores (Coeff = 1.38; 95% CI = 0.65, 2.11; p > z < 0.01), when compared with neurologists' responses. No association was found between ChatGPT' responses and mean satisfaction (Coeff = 0.03; 95% CI = - 0.01, 0.07; p = 0.157). College graduate, when compared with high school education responder, had significantly lower likelihood to prefer ChatGPT response (IRR = 0.87; 95% CI = 0.79, 0.95; p < 0.01).

CONCLUSIONS:

ChatGPT-authored responses provided higher empathy than neurologists. Although AI holds potential, physicians should prepare to interact with increasingly digitized patients and guide them on responsible AI use. Future development should consider tailoring AIs' responses to individual characteristics. Within the progressive digitalization of the population, ChatGPT could emerge as a helpful support in healthcare management rather than an alternative.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Artificial Intelligence / Empathy / Neurologists / Multiple Sclerosis Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Artificial Intelligence / Empathy / Neurologists / Multiple Sclerosis Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Neurol Year: 2024 Document type: Article